Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis.

Dolan SB, Shetty RA, Forster MJ, Gatch MB.

J Psychopharmacol. 2018 Jul;32(7):802-810. doi: 10.1177/0269881118780613. Epub 2018 Jun 18.

PMID:
29909719
2.

Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Gatch MB, Dolan SB, Forster MJ.

Behav Pharmacol. 2016 Sep;27(6):497-505. doi: 10.1097/FBP.0000000000000237.

3.

Effect of N-Benzylpiperazine, Its Metabolite N-Benzylethylenediamine, and Its Disubstituted Analogue N,N'-Dibenzylpiperazine on the Acquisition, Formation, and Consolidation of Memory in Mice.

Castillo-Hernández JC, Velázquez-Moyado JA, Reyes-Ramírez A, Ramírez-López EG, González-Andrade M, Navarrete A.

Pharmacology. 2017;99(5-6):268-274. doi: 10.1159/000457905. Epub 2017 Feb 21.

PMID:
28219076
4.

N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.

Neuropsychopharmacology. 2005 Mar;30(3):550-60.

5.

MDMA-like behavioral effects of N-substituted piperazines in the mouse.

Yarosh HL, Katz EB, Coop A, Fantegrossi WE.

Pharmacol Biochem Behav. 2007 Nov;88(1):18-27. Epub 2007 Jul 6.

6.

Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Dolan SB, Forster MJ, Gatch MB.

Drug Alcohol Depend. 2017 Nov 1;180:39-45. doi: 10.1016/j.drugalcdep.2017.07.041. Epub 2017 Aug 24.

7.

Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.

Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A.

Drug Alcohol Depend. 2005 Feb 14;77(2):161-8.

PMID:
15664717
8.

Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Gatch MB, Dolan SB, Forster MJ.

Behav Pharmacol. 2017 Aug;28(5):375-385. doi: 10.1097/FBP.0000000000000309.

9.

Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.

Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.

Ann N Y Acad Sci. 2004 Oct;1025:189-97.

PMID:
15542717
10.

Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.

Gatch MB, Dolan SB, Forster MJ.

Psychopharmacology (Berl). 2017 Apr;234(8):1237-1245. doi: 10.1007/s00213-017-4562-4. Epub 2017 Feb 16.

11.

Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.

Saber I, Milewski A, Reitz AB, Rawls SM, Walker EA.

Psychopharmacology (Berl). 2019 Mar;236(3):1015-1029. doi: 10.1007/s00213-019-05241-z. Epub 2019 Apr 13.

PMID:
30980094
12.

Abuse liability profile of three substituted tryptamines.

Gatch MB, Forster MJ, Janowsky A, Eshleman AJ.

J Pharmacol Exp Ther. 2011 Jul;338(1):280-9. doi: 10.1124/jpet.111.179705. Epub 2011 Apr 7.

14.

Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.

Gatch MB, Rutledge MA, Carbonaro T, Forster MJ.

Psychopharmacology (Berl). 2009 Jul;204(4):715-24. doi: 10.1007/s00213-009-1501-z. Epub 2009 Mar 14.

15.

Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.

Lee H, Wang GY, Curley LE, Kydd RR, Kirk IJ, Russell BR.

Psychopharmacology (Berl). 2016 Aug;233(15-16):2869-77. doi: 10.1007/s00213-016-4335-5. Epub 2016 Jun 11.

PMID:
27289365
16.

Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.

Gatch MB, Dolan SB, Forster MJ.

Drug Alcohol Depend. 2019 Jun 1;199:50-58. doi: 10.1016/j.drugalcdep.2019.02.016. Epub 2019 Apr 6.

PMID:
30986635
17.

In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.

Dias da Silva D, Silva MJ, Moreira P, Martins MJ, Valente MJ, Carvalho F, Bastos ML, Carmo H.

Arch Toxicol. 2017 Mar;91(3):1413-1430. doi: 10.1007/s00204-016-1777-9. Epub 2016 Jun 29.

PMID:
27358233
18.

Benzylpiperazine: a drug of abuse?

Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS.

J Psychopharmacol. 2007 Nov;21(8):888-94. Epub 2007 Jul 2. Review.

PMID:
17606471
19.

Estrogenic effects and their action mechanism of the major active components of party pill drugs.

Min CR, Kim MJ, Park YJ, Kim HR, Lee SY, Chung KH, Oh SM.

Toxicol Lett. 2012 Nov 15;214(3):339-47. doi: 10.1016/j.toxlet.2012.09.014. Epub 2012 Sep 28.

PMID:
23026265
20.

N-benzylpiperazine has characteristics of a drug of abuse.

Brennan KA, Lake B, Hely LS, Jones K, Gittings D, Colussi-Mas J, Fitzmaurice PS, Lea RA, Schenk S.

Behav Pharmacol. 2007 Dec;18(8):785-90.

PMID:
17989516

Supplemental Content

Support Center